Cargando…

The difference in mean arterial pressure induced by remimazolam compared to etomidate in the presence of fentanyl at tracheal intubation: A randomized controlled trial

Background: Combined use of hypnotic and opioids during anesthesia inductions decreases blood pressure. Post-induction hypotension (PIHO) is the most common side effect of anesthesia induction. We aimed to compare the difference in mean arterial pressure (MAP) induced by remimazolam with that induce...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xiaofang, Cao, Huiyu, Zhang, Cuiwen, Lan, Hongmeng, Gong, Xiaofang, Li, Ruijie, Lin, Yan, Xu, Bing, Chen, Huihe, Guan, Xuehai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067562/
https://www.ncbi.nlm.nih.gov/pubmed/37021047
http://dx.doi.org/10.3389/fphar.2023.1143784
_version_ 1785018499069902848
author Huang, Xiaofang
Cao, Huiyu
Zhang, Cuiwen
Lan, Hongmeng
Gong, Xiaofang
Li, Ruijie
Lin, Yan
Xu, Bing
Chen, Huihe
Guan, Xuehai
author_facet Huang, Xiaofang
Cao, Huiyu
Zhang, Cuiwen
Lan, Hongmeng
Gong, Xiaofang
Li, Ruijie
Lin, Yan
Xu, Bing
Chen, Huihe
Guan, Xuehai
author_sort Huang, Xiaofang
collection PubMed
description Background: Combined use of hypnotic and opioids during anesthesia inductions decreases blood pressure. Post-induction hypotension (PIHO) is the most common side effect of anesthesia induction. We aimed to compare the difference in mean arterial pressure (MAP) induced by remimazolam with that induced by etomidate in the presence of fentanyl at tracheal intubation. Methods: We assessed 138 adult patients with American Society of Anesthesiologists physical status I–II who underwent elective urological surgery. Patients were randomly allocated to receive either remimazolam or etomidate as alterative hypnotic in the presence of fentanyl during anesthesia induction. Comparable BIS values were achieved in both groups. The primary outcome was the difference in the MAP at tracheal intubation. The secondary outcomes included the characteristics of anesthesia, surgery, and adverse effects. Results: The MAP was higher in the etomidate group than in the remimazolam group at tracheal intubation (108 [22] mmHg vs. 83 [16] mmHg; mean difference, −26; 95% confidence interval [CI], −33 to −19; p < 0.0001). Heart rate was significantly higher in the etomidate group than in the remimazolam group at tracheal intubation. The patients’ condition warranted the administration of ephedrine more frequently in the remimazolam group (22%) than in the etomidate group (5%) (p = 0.0042) during anesthesia induction. The remimazolam group had a lower incidence of hypertension (0% vs. 9%, p = 0.0133), myoclonus (0% vs. 47%, p < 0.001), and tachycardia (16% vs. 35%, p = 0.0148), and a higher incidence of PIHO (42% vs. 5%, p = 0.001) than the etomidate group during anesthesia induction. Conclusion: Remimazolam was associated with lower MAP and lower heart rate compared to etomidate in the presence of fentanyl at tracheal intubation. Patients in the remimazolam group had a higher incidence of PIHO, and their condition warranted the administration of ephedrine more frequently than in the etomidate group during anesthesia induction.
format Online
Article
Text
id pubmed-10067562
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100675622023-04-04 The difference in mean arterial pressure induced by remimazolam compared to etomidate in the presence of fentanyl at tracheal intubation: A randomized controlled trial Huang, Xiaofang Cao, Huiyu Zhang, Cuiwen Lan, Hongmeng Gong, Xiaofang Li, Ruijie Lin, Yan Xu, Bing Chen, Huihe Guan, Xuehai Front Pharmacol Pharmacology Background: Combined use of hypnotic and opioids during anesthesia inductions decreases blood pressure. Post-induction hypotension (PIHO) is the most common side effect of anesthesia induction. We aimed to compare the difference in mean arterial pressure (MAP) induced by remimazolam with that induced by etomidate in the presence of fentanyl at tracheal intubation. Methods: We assessed 138 adult patients with American Society of Anesthesiologists physical status I–II who underwent elective urological surgery. Patients were randomly allocated to receive either remimazolam or etomidate as alterative hypnotic in the presence of fentanyl during anesthesia induction. Comparable BIS values were achieved in both groups. The primary outcome was the difference in the MAP at tracheal intubation. The secondary outcomes included the characteristics of anesthesia, surgery, and adverse effects. Results: The MAP was higher in the etomidate group than in the remimazolam group at tracheal intubation (108 [22] mmHg vs. 83 [16] mmHg; mean difference, −26; 95% confidence interval [CI], −33 to −19; p < 0.0001). Heart rate was significantly higher in the etomidate group than in the remimazolam group at tracheal intubation. The patients’ condition warranted the administration of ephedrine more frequently in the remimazolam group (22%) than in the etomidate group (5%) (p = 0.0042) during anesthesia induction. The remimazolam group had a lower incidence of hypertension (0% vs. 9%, p = 0.0133), myoclonus (0% vs. 47%, p < 0.001), and tachycardia (16% vs. 35%, p = 0.0148), and a higher incidence of PIHO (42% vs. 5%, p = 0.001) than the etomidate group during anesthesia induction. Conclusion: Remimazolam was associated with lower MAP and lower heart rate compared to etomidate in the presence of fentanyl at tracheal intubation. Patients in the remimazolam group had a higher incidence of PIHO, and their condition warranted the administration of ephedrine more frequently than in the etomidate group during anesthesia induction. Frontiers Media S.A. 2023-03-20 /pmc/articles/PMC10067562/ /pubmed/37021047 http://dx.doi.org/10.3389/fphar.2023.1143784 Text en Copyright © 2023 Huang, Cao, Zhang, Lan, Gong, Li, Lin, Xu, Chen and Guan. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Huang, Xiaofang
Cao, Huiyu
Zhang, Cuiwen
Lan, Hongmeng
Gong, Xiaofang
Li, Ruijie
Lin, Yan
Xu, Bing
Chen, Huihe
Guan, Xuehai
The difference in mean arterial pressure induced by remimazolam compared to etomidate in the presence of fentanyl at tracheal intubation: A randomized controlled trial
title The difference in mean arterial pressure induced by remimazolam compared to etomidate in the presence of fentanyl at tracheal intubation: A randomized controlled trial
title_full The difference in mean arterial pressure induced by remimazolam compared to etomidate in the presence of fentanyl at tracheal intubation: A randomized controlled trial
title_fullStr The difference in mean arterial pressure induced by remimazolam compared to etomidate in the presence of fentanyl at tracheal intubation: A randomized controlled trial
title_full_unstemmed The difference in mean arterial pressure induced by remimazolam compared to etomidate in the presence of fentanyl at tracheal intubation: A randomized controlled trial
title_short The difference in mean arterial pressure induced by remimazolam compared to etomidate in the presence of fentanyl at tracheal intubation: A randomized controlled trial
title_sort difference in mean arterial pressure induced by remimazolam compared to etomidate in the presence of fentanyl at tracheal intubation: a randomized controlled trial
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067562/
https://www.ncbi.nlm.nih.gov/pubmed/37021047
http://dx.doi.org/10.3389/fphar.2023.1143784
work_keys_str_mv AT huangxiaofang thedifferenceinmeanarterialpressureinducedbyremimazolamcomparedtoetomidateinthepresenceoffentanylattrachealintubationarandomizedcontrolledtrial
AT caohuiyu thedifferenceinmeanarterialpressureinducedbyremimazolamcomparedtoetomidateinthepresenceoffentanylattrachealintubationarandomizedcontrolledtrial
AT zhangcuiwen thedifferenceinmeanarterialpressureinducedbyremimazolamcomparedtoetomidateinthepresenceoffentanylattrachealintubationarandomizedcontrolledtrial
AT lanhongmeng thedifferenceinmeanarterialpressureinducedbyremimazolamcomparedtoetomidateinthepresenceoffentanylattrachealintubationarandomizedcontrolledtrial
AT gongxiaofang thedifferenceinmeanarterialpressureinducedbyremimazolamcomparedtoetomidateinthepresenceoffentanylattrachealintubationarandomizedcontrolledtrial
AT liruijie thedifferenceinmeanarterialpressureinducedbyremimazolamcomparedtoetomidateinthepresenceoffentanylattrachealintubationarandomizedcontrolledtrial
AT linyan thedifferenceinmeanarterialpressureinducedbyremimazolamcomparedtoetomidateinthepresenceoffentanylattrachealintubationarandomizedcontrolledtrial
AT xubing thedifferenceinmeanarterialpressureinducedbyremimazolamcomparedtoetomidateinthepresenceoffentanylattrachealintubationarandomizedcontrolledtrial
AT chenhuihe thedifferenceinmeanarterialpressureinducedbyremimazolamcomparedtoetomidateinthepresenceoffentanylattrachealintubationarandomizedcontrolledtrial
AT guanxuehai thedifferenceinmeanarterialpressureinducedbyremimazolamcomparedtoetomidateinthepresenceoffentanylattrachealintubationarandomizedcontrolledtrial
AT huangxiaofang differenceinmeanarterialpressureinducedbyremimazolamcomparedtoetomidateinthepresenceoffentanylattrachealintubationarandomizedcontrolledtrial
AT caohuiyu differenceinmeanarterialpressureinducedbyremimazolamcomparedtoetomidateinthepresenceoffentanylattrachealintubationarandomizedcontrolledtrial
AT zhangcuiwen differenceinmeanarterialpressureinducedbyremimazolamcomparedtoetomidateinthepresenceoffentanylattrachealintubationarandomizedcontrolledtrial
AT lanhongmeng differenceinmeanarterialpressureinducedbyremimazolamcomparedtoetomidateinthepresenceoffentanylattrachealintubationarandomizedcontrolledtrial
AT gongxiaofang differenceinmeanarterialpressureinducedbyremimazolamcomparedtoetomidateinthepresenceoffentanylattrachealintubationarandomizedcontrolledtrial
AT liruijie differenceinmeanarterialpressureinducedbyremimazolamcomparedtoetomidateinthepresenceoffentanylattrachealintubationarandomizedcontrolledtrial
AT linyan differenceinmeanarterialpressureinducedbyremimazolamcomparedtoetomidateinthepresenceoffentanylattrachealintubationarandomizedcontrolledtrial
AT xubing differenceinmeanarterialpressureinducedbyremimazolamcomparedtoetomidateinthepresenceoffentanylattrachealintubationarandomizedcontrolledtrial
AT chenhuihe differenceinmeanarterialpressureinducedbyremimazolamcomparedtoetomidateinthepresenceoffentanylattrachealintubationarandomizedcontrolledtrial
AT guanxuehai differenceinmeanarterialpressureinducedbyremimazolamcomparedtoetomidateinthepresenceoffentanylattrachealintubationarandomizedcontrolledtrial